| Q50310620 | A high-density SNP genome-wide linkage scan in a large autism extended pedigree |
| Q34495960 | Abnormal emotional learning in a rat model of autism exposed to valproic acid in utero |
| Q48165183 | Abnormal fear conditioning and amygdala processing in an animal model of autism |
| Q36937876 | Advances in behavioral genetics: mouse models of autism |
| Q35200121 | Altered behavioral development in Nrf2 knockout mice following early postnatal exposure to valproic acid. |
| Q34568411 | Animal models of restricted repetitive behavior in autism |
| Q38134413 | Approaches for strengthening causal inference regarding prenatal risk factors for childhood behavioural and psychiatric disorders |
| Q37068738 | Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses |
| Q48666558 | Bacopa monniera (L.) Wettst ameliorates behavioral alterations and oxidative markers in sodium valproate induced autism in rats |
| Q44967603 | Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism |
| Q39324090 | Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism. |
| Q41918229 | Blockage of VIP during mouse embryogenesis modifies adult behavior and results in permanent changes in brain chemistry. |
| Q29547388 | Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models |
| Q55180784 | Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder. |
| Q50311389 | De novo partial duplication of chromosome 7p in a male with autistic disorder |
| Q35017799 | Decreased mTOR signaling pathway in human idiopathic autism and in rats exposed to valproic acid |
| Q30487709 | Deficient brainstem encoding of pitch in children with Autism Spectrum Disorders |
| Q35201057 | Dermatologic and nondermatologic uses of thalidomide |
| Q34978971 | Differences between children and adults: implications for risk assessment at California EPA. |
| Q35609013 | Disruption in the inhibitory architecture of the cell minicolumn: implications for autism |
| Q34460570 | Disturbance of phasic chin muscle activity during rapid-eye-movement sleep |
| Q37208939 | Early behavioral intervention, brain plasticity, and the prevention of autism spectrum disorder |
| Q93035979 | Effects of PM2.5 and gases exposure during prenatal and early-life on autism-like phenotypes in male rat offspring |
| Q35941298 | Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid |
| Q48171068 | Elevated microRNA-181c and microRNA-30d levels in the enlarged amygdala of the valproic acid rat model of autism |
| Q33987401 | Environmental enrichment reverses behavioral alterations in rats prenatally exposed to valproic acid: issues for a therapeutic approach in autism |
| Q42513699 | Etiology and pathophysiology of autistic behavior: clues from two cases with an unusual variant of neuroaxonal dystrophy |
| Q26825821 | From genes to environment: using integrative genomics to build a "systems-level" understanding of autism spectrum disorders |
| Q37039400 | General developmental health in the VPA-rat model of autism |
| Q26741618 | Genetic Syndromes, Maternal Diseases and Antenatal Factors Associated with Autism Spectrum Disorders (ASD) |
| Q27687011 | Genetic aspects of autism spectrum disorders: insights from animal models |
| Q37623398 | Habituation of exploratory behaviour in VPA rats: animal model of autism |
| Q36966253 | Hyper-connectivity and hyper-plasticity in the medial prefrontal cortex in the valproic Acid animal model of autism |
| Q27308689 | Impaired Processing in the Primary Auditory Cortex of an Animal Model of Autism. |
| Q34125907 | In utero exposure to valproic acid changes sleep in juvenile rats: a model for sleep disturbances in autism |
| Q33560820 | Increased BDNF expression in fetal brain in the valproic acid model of autism |
| Q48400359 | Increased GABAA receptor binding in amygdala after prenatal administration of valproic acid to rats. |
| Q37227405 | Increased IgG4 levels in children with autism disorder |
| Q37204659 | Increased expression of fatty acid synthase and acetyl-CoA carboxylase in the prefrontal cortex and cerebellum in the valproic acid model of autism |
| Q44161291 | Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: putative animal models for autism |
| Q28388355 | Infant siblings and the investigation of autism risk factors |
| Q89997980 | Larval zebrafish model for studying the effects of valproic acid on neurodevelopment: An approach towards modeling autism |
| Q90857847 | Maternal valproic acid exposure leads to neurogenesis defects and autism-like behaviors in non-human primates |
| Q64963896 | MicroRNA-153 promotes brain-derived neurotrophic factor and hippocampal neuron proliferation to alleviate autism symptoms through inhibition of JAK-STAT pathway by LEPR. |
| Q34575629 | Minor physical anomalies in children with autism spectrum disorders |
| Q34517515 | Molecular genetics and animal models in autistic disorder |
| Q34817846 | Neuroimaging endophenotypes in animal models of autism spectrum disorders: lost or found in translation? |
| Q28396205 | Neuronal connectivity as a convergent target of gene × environment interactions that confer risk for Autism Spectrum Disorders |
| Q38726690 | Neuroteratology and Animal Modeling of Brain Disorders |
| Q38618627 | Perinatal Influences of Valproate on Brain and Behaviour: An Animal Model for Autism |
| Q80407445 | Perinatal exposure to polychlorinated biphenyls differentially affects cerebellar development and motor functions in male and female rat neonates |
| Q34432742 | Polysomnographical assessment of the pathophysiology of West syndrome |
| Q30436913 | Pre-clinical models of neurodevelopmental disorders: focus on the cerebellum |
| Q35675589 | Predictable enriched environment prevents development of hyper-emotionality in the VPA rat model of autism |
| Q48683042 | Prefrontal cortex, hippocampus, and basolateral amygdala plasticity in a rat model of autism spectrum |
| Q30473609 | Prenatal VPA Exposure and Changes in Sensory Processing by the Superior Colliculus |
| Q48170689 | Prenatal exposure to valproic acid disturbs the enkephalinergic system functioning, basal hedonic tone, and emotional responses in an animal model of autism |
| Q64078960 | Prevention or Amelioration of Autism-Like Symptoms in Animal Models: Will it Bring Us Closer to Treating Human ASD? |
| Q37434887 | Proposed toxic and hypoxic impairment of a brainstem locus in autism |
| Q52585561 | RDoC-based categorization of amygdala functions and its implications in autism. |
| Q50301130 | Receptive communication in late-stage Rett syndrome: a cautionary note |
| Q55340060 | Resveratrol Prevents Cellular and Behavioral Sensory Alterations in the Animal Model of Autism Induced by Valproic Acid. |
| Q34585320 | Review article: the concept of entero-colonic encephalopathy, autism and opioid receptor ligands |
| Q36462150 | Review of animal models for autism: implication of thyroid hormone |
| Q41290267 | Similarities in genetic mental retardation and neuroteratogenic syndromes |
| Q34588189 | Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism |
| Q48612658 | Subcortical arousal response in child patients with obstructive sleep apnea |
| Q34216349 | Synaptic and intrinsic balancing during postnatal development in rat pups exposed to valproic acid in utero |
| Q24553624 | The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism |
| Q27500386 | The Intense World Theory – A Unifying Theory of the Neurobiology of Autism |
| Q35134560 | The developing brain and the environment: an introduction |
| Q34871941 | The intense world syndrome--an alternative hypothesis for autism |
| Q42729995 | The pathophysiology of restricted repetitive behavior |
| Q28277009 | The ups and downs of Wnt signaling in prevalent neurological disorders |
| Q21284783 | What We Have Learned about Autism Spectrum Disorder from Valproic Acid |
| Q52933135 | [Neuropsychological outcome following intrauterine exposure to valproate]. |